622-Instituto Medico Damic Srl

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Schizophrenia2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• ACADIA Pharmaceuticals Inc.2 trials

Closed trials

• Completed

  Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

  NCT04531982· Phase 3· ACADIA Pharmaceuticals Inc.· Source

• Terminated

  Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

  NCT03121586· Phase 3· ACADIA Pharmaceuticals Inc.· Source